Comparison Overview
Gland Pharma Limited
Gland Pharma Limited
Sy. No: 143 to 148/150&151, DP Pally Near Gandimaisamma X Road, Hyderabad, Telangana, 500 043, IN
Last Update: 11/12/2025
Established in Hyderabad, India in 1978, Gland Pharma is one of the fastest-growing small-molecule generic injectables-focused company, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets in the re...
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd, Ahmedabad, 380015, IN
Last Update: 02/04/2026
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (...
Compliance Ranges Comparison
Gland Pharma Limited
Torrent Pharmaceuticals Ltd
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Gland Pharma Limited in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Torrent Pharmaceuticals Ltd in 2026.
Incident History - Gland Pharma Limited (X = Date, Y = Severity)
Gland Pharma Limited cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Torrent Pharmaceuticals Ltd (X = Date, Y = Severity)
Torrent Pharmaceuticals Ltd cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Gland Pharma Limited
Torrent Pharmaceuticals Ltd
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.